Anthropic's Clash with U.S. Government Threatens Its IPO Roadmap

Rising regulatory pressure in Washington pushes Anthropic's valuation and upcoming IPO into uncertainty.

Pentagon Flags Supply‑Chain Risk

The U.S. Department of Defense labeled Anthropic a "supply‑chain risk" after the firm refused contract language, casting doubt on its $965 billion valuation and imminent public offering.

Export Controls Stall Model Deployments

■Mythos and Fable models were fully disabled after a two‑week export ban.

■OpenAI postponed the broad release of its GPT‑5.6 model at the request of the U.S. government.

■The easing of controls still limits Anthropic's ability to focus solely on the U.S. market.

Political Friction's Corporate Fallout

■CEO Dario Amodei and his team were singled out by Trump administration officials, portrayed as “left‑wing” agitators.

■The company hired former Biden‑era policy advisers to build a strategic foothold in Washington.

■Rival OpenAI adopted a more conciliatory approach, staffing its policy team with figures favored by the Trump circle.

Market Implications

■Uncertainty around the IPO could depress Anthropic's pricing and investor demand.

■Increased defense spending and heightened regulatory risk may pressure the broader tech‑focused equity segment.

■Investor risk appetite may contract, especially for firms with high regulatory sensitivity.

Gökberk Uçar – Aviation Freight and Logistics Specialist: This episode underscores how political volatility can directly impact tech‑centric capital markets. The postponement of Anthropic's IPO serves as a clear signal that regulatory risk is now a pricing factor; investors would be prudent to adopt a cautious stance and diversify their holdings.